Biote (BTMD) Cost of Revenue (2021 - 2026)

Biote (BTMD) has reported Cost of Revenue for 6 consecutive years, with $14.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cost of Revenue rose 10.88% year-over-year to $14.0 million; the TTM figure through Mar 2026 stood at $56.2 million (down 1.85% YoY), while the FY2025 annual figure was $54.9 million, down 5.63% from the prior year.
• Cost of Revenue came in at $14.0 million for Q1 2026 at Biote, down from $14.8 million in the prior quarter.
• The five-year high for Cost of Revenue was $15.8 million in Q2 2023, with the low at $12.3 million in Q1 2022.
• Average Cost of Revenue over 5 years is $14.1 million, with a median of $14.0 million recorded in 2026.
• The largest YoY upside for Cost of Revenue was 841.21% in 2022 against a maximum downside of 66.17% in 2022.
• Year by year, Cost of Revenue stood at $15.4 million in 2022, then slipped by 9.2% to $14.0 million in 2023, then gained by 0.24% to $14.0 million in 2024, then gained by 5.67% to $14.8 million in 2025, then retreated by 5.75% to $14.0 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $14.0 million, $14.8 million, and $13.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.